America First Investment Advisors, LLC Abb Vie Inc. Transaction History

America First Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $14,316 - $16,487	-99 Reduced 33.0%	201 $32,000
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $17,849 - $20,472	-133 Reduced 30.72%	300 $40,000
Q2 2020 Jul 16, 2020	SELL	$73.37 - $98.18 $22,377 - $29,944	-305 Reduced 41.33%	433 $43,000
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $15,931 - $24,154	-247 Reduced 25.08%	738 $56,000
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $9,526 - $12,177	-145 Reduced 12.83%	985 $72,000
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $14,888 - $17,522	-193 Reduced 14.59%	1,130 $91,000
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $16,101 - $21,561	-175 Reduced 11.68%	1,323 $125,000
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $15,673 - $17,186	-175 Reduced 10.46%	1,498 $145,000
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $116,859 - $149,265	1,673	1,673 $149,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of America First Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on America First Investment Advisors, LLC with notifications on news.